	Association of tumor-infiltrating lymphocytes and proinflammatory biomarkers with breast cancer molecular subtypes: analysis of the MEND study. Breast Cancer Res Treat Byemerwa J, Neish D, Forgah L, Deveaux A, Osazuwa-Peters O, Joshi A, Salako O, Daramola A, Alatise O, Ogun G, Hall A, Adeniyi A, Ayandipo O, Olajide T, Olasehinde O, Arowolo O, Adisa A, Afuwape O, Olusanya A, Adegoke A, Tollefsbol TO, Arnett D, Muehlbauer MJ, Akinyemiju T. PMID: 42432165 [PubMed - in process]
	Lymphatic and Vascular Dual-System Super-Resolution Ultrasound for Diagnosing Sentinel Lymph Node Metastasis in Breast Cancer: A Prospective Study. Ultrasound Med Biol Li H, Wang H, Yao J, Cui S, Chang C, Deng M, Chen S, Zhang F. PMID: 42431777 [PubMed - as supplied by publisher]
	Minimal Clinically Important Differences to Determine Meaningful Change in the Skin Symptom Assessment (SSA) Questionnaire for the Randomized Controlled Trial of Mepitel Film Versus Standard of Care for the Prevention of Acute and Chronic Dermatitis in Breast Cancer Radiation Treatment. Clin Breast Cancer Yang C, Tang L, Zhang L, Karam I, Lam J, Spadafora S, Chen H, Hircock C, Raman S, Lee SF, Wong HCY, Chow E. PMID: 42431149 [PubMed - as supplied by publisher]
	Tucatinib in Combination With Trastuzumab Deruxtecan in Patients With Previously Treated HER2+ Unresectable Locally Advanced or Metastatic Breast Cancer: An Open-Label Phase 2 Study. Clin Breast Cancer Modi S, Murthy RK, Chien AJ, Lin NU, McAndrew NP, Specht JM, Zelnak AB, Ramos J, Xie D, Ho J, Inoue JK, Carey LA, Hamilton EP. PMID: 42431148 [PubMed - as supplied by publisher]
	Home-based high-intensity exercise training during neoadjuvant chemotherapy is associated with favorable chemotherapy outcomes and tumor microenvironment remodeling in breast cancer. Cell Commun Signal Skorinkina D, Egl, Zayakin P, Mlynska A, Martin-Gracia B, Bassols-Citores E, Sadovska L, Brok, Rise F, Sagini K, Romero S, Gkelis K, Zablocka T, , Ce, K, Liepniece-Karele I, Egl, Silina K, Llorente A, Lin. PMID: 42432678 [PubMed - as supplied by publisher]
	Lower blood glucose levels (HbA1c) within the non-diabetic range are associated with improved survival in patients diagnosed with lung, colon and ovarian cancer: an explorative study. BMC Cancer Abrahamsen O, Schou JHV, Johansen JS, Jensen MB, Lykke J, Høgdall C, Budtz-Jørgensen E, Høgdall E. PMID: 42432556 [PubMed - as supplied by publisher]
	Neoadjuvant Chemotherapy with Trastuzumab with or without Concurrent Radiotherapy in HER2-Positive Locally Advanced Inoperable Breast Cancer- A Phase 2 Randomized Controlled Trial (NEOTRAC STUDY). Int J Radiat Oncol Biol Phys Iyer P, Krishnamurthy A, Velusamy S, Sundersingh S, Rajaram S, Venkatraman P, Varadarajan M, Gunasekaran M, Selvarajan G, Radhakrishnan V. PMID: 42431330 [PubMed - as supplied by publisher]
	Local ablative treatment and continuation of systemic therapy for oligoprogressive metastatic breast cancer: a retrospective cohort study. Cancer Treat Res Commun Almekinders CAM, Snellen TIM, van Ommen-Nijhof A, Steenbruggen TG, Klompenhouwer EG, Kok NFM, Kuhlmann KFD, van Duijnhoven F, Bos MEMM, Wiersma TG, Dezentjé VO, Sonke GS. PMID: 42430886 [PubMed - as supplied by publisher]
	Real-Time Integration of Patient-Reported Outcomes in Breast Cancer Surgery: Feasibility of the BREAST-Q REACT. Plast Reconstr Surg Gabay AJ, Abu El Hawa A, Boe L, Dinh-Do D, Rakauskas A, Kim M, Stern CS, Mehrara BJ, Tadros A, Nelson JA. PMID: 42430729 [PubMed - as supplied by publisher]
	Applications of Large Language Models in Ovarian Cancer Management: Protocol for a Systematic Review and Meta-Analysis. JMIR Res Protoc Wang Y, Yao J, Tian J, Wang Y, Yang Y. PMID: 42430510 [PubMed - indexed for MEDLINE]
	Understanding barriers and facilitators to cervical cancer prevention among young Korean Women: A focus group interview study. PLoS One Kim HJ, Lee HJ, Shin HY, Lee HS, Jun JK, Choi KS, Suh M. PMID: 42430333 [PubMed - indexed for MEDLINE]
	Establishing a Multimodal Model for Predicting Lymphovascular Invasion in Breast Cancer Using Deep Transfer Learning Based on Ultrasound and Dynamic Contrast-Enhanced Magnetic Resonance Imaging. Oncol Res Treat He M, Zhu F, Jiang F, Liu Y, Guo Y, Yang Y, Jiang H, Xiong F, Cheng W, Xu Z, Liu B. PMID: 42430299 [PubMed - as supplied by publisher]
	Population-Level Outcomes for Screening Program Cancers in First Nations People in Ontario, Canada. JAMA Netw Open Sheppard AJ, Sutradhar R, Liu N, Kewayosh A, Leylachian S, Senese L, Ianni A, Hyett S, Chiarelli AM, Kupets R, Tammemägi CM, Tinmouth J. PMID: 42430169 [PubMed - indexed for MEDLINE]
	Early first-line systemic anticancer therapeutic attrition after metastatic recurrence in triple-negative breast cancer following neoadjuvant chemo-immunotherapy: a multicenter real-world study. Breast Cancer Res Treat Fedele P, Rizzo A, Landriscina M, Stucci LS, Inneo C, Morritti M, Morelli F, Giuliani F, Moraca L, Cairo G, Giampaglia M, Tedesco B, Melaccio A, Maselli FM, Gnoni A, Licchetta A, Fumai F, Vitale E, Marino FR, Zifarone E, Lanotte L, Ardito R, Gadaleta-Caldarola G. PMID: 42430019 [PubMed - indexed for MEDLINE]
	Breast cancer screening adherence after multigene panel testing among women with pathogenic variants in moderate-risk genes or with empirically increased breast cancer risk. Breast Cancer Res Treat Comeaux JG, Gutierrez N, Ricker CN, Nie Q, Nguyen A, Garcia I, Chang EY, Waggoner RM, Groshen S, Lerman C, Spicer D, Culver JO. PMID: 42430009 [PubMed - indexed for MEDLINE]
	Retinoic acid disrupts cumulus granulosa cells function via EGFR downregulation: induction of PCOS and infertility in adult female mice. Histochem Cell Biol Said A, Marzouk M, Mahmoud A, Emad M, Elkhbery M, Alwutayd KM, Alkhateeb MA, Aldawsari MA, Shokry AE, AbdElkhalek AS. PMID: 42429978 [PubMed - indexed for MEDLINE]
	EVERolimus effectiveness after proGREssion on ENdocrine therapy plus CDK4/6 inhibitor for ER-positive/HER2-negative advanced breast cancer: EVERGREEN study. Breast Cancer Res Treat Martins-Branco D, Lobo-Martins S, Aftimos P, Pereira B, Vasconcelos de Matos L, Fernandes L, Campôa E, Nader-Marta G, Moreau M, Taylor D, Duhoux FP, Simões P, Garcia AR, Patel V, Confente C, Alpuim Costa D, Pereira J, Santos C, Paesmans M, Sarmento F, Gantes Padrão T, Simão D, Bandarra D, Sousa B, Brito M, Gombos A, Ameye L, de Azambuja E. PMID: 42429895 [PubMed - indexed for MEDLINE]
	Impact of trop-2 expression on the efficacy of trop-2-targeted antibody-drug conjugates in metastatic breast cancer: a systematic review and meta-analysis. J Natl Cancer Inst Buonaiuto R, Pagliuca M, Longobardi A, Cataldo ML, Arecco L, Gerosa R, Gentile G, Caltavituro A, Barone I, Karakose B, Agostinetto E, Sotiriou C, De Laurentiis M, De Azambuja E, De Angelis C. PMID: 42429566 [PubMed - as supplied by publisher]
	p16/Ki-67 dual-stain immunocytochemistry in precision cervical cancer prevention: immunoprofile and clinical decision-making. Pol J Pathol Trzeszcz M, Jach R. PMID: 42429429 [PubMed - indexed for MEDLINE]
	Immunohistochemical and molecular diagnostics tailoring personalised ovarian cancer therapy. Pol J Pathol Kowalewski AM, Szylberg . PMID: 42429424 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 331947

Page 1 of 16598



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy